Helius Medical gets Nasdaq delisting warning for equity <$2.5M; extension to June 30, 2025

Solana Co

Received Nasdaq notice on March 31, 2025 for stockholders' equity below $2.5M from FY2024 10-K.
Also failed minimum bid price requirement; hearing held March 18, 2025.
Company does not meet alternative compliance standards for continued listing.
Nasdaq granted extension to June 30, 2025 to regain compliance with both rules.
Stock continues trading on Nasdaq under HSDT with no immediate impact.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.